Abstract:Background Down syndrome (DS) is caused by trisomy 21, leading to increased risks of Alzheimer's disease (AD) and Obstructive sleep apnea (OSA). Traditional diagnostic methods for AD and OSA, like cerebrospinal fluid analysis and polysomnography, are invasive and challenging for people with DS. Facial morphology has emerged as a non-invasive biomarker for these conditions. Therefore, we conducted a comprehensive 3D analysis of facial shape variation in DS and euploid control (EU) populations, assessing the effect of critical factors such as age, sex, and facial size, to investigate its association with AD and OSA. Methods Facial shape differences among groups were analyzed from the coordinates of 21 landmarks automatically registered on 3D facial models generated from head magnetic resonance images in a cross-sectional sample of 131 individuals with DS and 216 EU controls from 18 to 90 years old, including subjects diagnosed with AD and OSA. We used Procrustes ANOVA and MANOVA tests to quantify the amount of facial shape variation attributable to sex, age, and facial size, and quantified facial shape differences among diagnostic groups using geometric morphometrics. Results Besides facial shape differences between DS and EU individuals, our results detected significant interactions between diagnosis and sex, and between diagnosis and age, indicating sex-dependent differences and an altered pattern of facial shape change over adulthood in DS, with females presenting more severe alterations. Multivariate regression analyses showed that facial shape significantly correlated with the concentration ratio between amyloid beta peptide 1-42 and amyloid beta peptide 1-40 (AB;1-42/AB1-40) in cerebrospinal fluid, a common biomarker for AD diagnosis. In the DS population, facial shape differences between individuals with and without AD diagnosis did not achieve statistical significance after adjusting for age and facial size, but significant shape differences were detected in the EU population. Regarding OSA, facial shape significantly correlated with the apnea-hypopnea index, and individuals with DS and severe OSA presented a significantly different facial morphology in comparison to individuals with DS and no signs of OSA, suggesting that facial morphology could be associated with sleep respiratory disturbances. Conclusions Overall, our study underscores the potential of facial morphology as a diagnostic biomarker for the early detection and clinical management of AD and OSA.

Down syndrome detection based on facial features using a geometric descriptor

Down syndrome detection from facial photographs using machine learning techniques

Automated Down Syndrome Detection Using Facial Photographs

Ensemble Learning for the Detection of Facial Dysmorphology

Identification of Dysmorphic Syndromes Using Landmark-Specific Local Texture Descriptors

Novel Transfer Learning Based Deep Features for Diagnosis of Down Syndrome in Children Using Facial Images

Facial analysis technology for the detection of Down syndrome in the Democratic Republic of the Congo

ASDFace: Face-based Autism Diagnosis Via Heterogeneous Domain Adaptation

Down syndrome in diverse populations

Application of human face recognition technology in genetic syndrome diagnosis

DS-CNN: Deep Convolutional Neural Networks for Facial Emotion Detection in Children with Down Syndrome during Dolphin-Assisted Therapy

Testing the Performance of Face Recognition for People with Down Syndrome

A 3D Clinical Face Phenotype Space of Genetic Syndromes using a Triplet-Based Singular Geometric Autoencoder

Unraveling Down Syndrome: From Genetic Anomaly to Artificial Intelligence-Enhanced Diagnosis

Digital facial dysmorphology for genetic screening: Hierarchical constrained local model using ICA

Various Methods for Computing Risk Factors of Down Syndrome in Fetus

Craniofacial and Airway Morphology in Down Syndrome: A Cone Beam Computed Tomography Case Series Evaluation

Hierarchical constrained local model using ICA and its application to Down syndrome detection.

Down Syndrome detection with Swin Transformer architecture

Potential of facial biomarkers for Alzheimer's disease and Obstructive sleep apnea in Down syndrome and general population

Automated syndrome diagnosis by three-dimensional facial imaging